Survival predictor for diffuse large B cell lymphoma

US11028444B2 · kind B2 · utility

Assignees

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US
• Arizona Board of Regents on Behalf of the University of Arizona · US
• QUEEN MARY UNIVERSITY OF LONDON · GB
• BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · US
• Oslo University Hospital HF · NO
• Oregon Health & Science University · US
• University of Rochester · US
• HOSPITAL CLÍNIC DE BARCELONA · ES
• UNIVERSITAT DE BARCELONA · ES
• British Columbia Cancer Agency Branch · CA
• Julius-Maximilians-Universitat Wurzburg · DE

Inventors

• Lisa M. Rimsza · Tucson, US
• Andrew T. Lister · London, GB
• Wing C. Chan · Pasadena, US
• Dennis Weisenburger · Glendora, US
• Jan Delabie · Toronto, CA
• Erlend B. Smeland · Oslo, NO
• Harald Holte · Oslo, NO
• Stein Kvaløy · Oslo, NO
• Rita M. Braziel · West Linn, US
• Richard I. Fisher · Pittsford, US
• Pedro Jares · Barcelona, ES
• Armando Lopez-Guillermo · Barcelona, ES
• Elias Campo Guerri · Barcelona, ES
• Elaine S. Jaffe · Great Falls, US
• Georg Lenz · Berlin, DE
• Wyndham Wilson · Washington, US
• George W. Wright · Rockville, US
• Sandeep Dave · Bethel, US
• Louis M. Staudt · Silver Spring, US
• Randy D. Gascoyne · North Vancouver, CA
• Joseph M. Connors · Vancouver, CA
• Hans-Konrad Muller-Hermelink · Würzburg, DE
• Andreas Rosenwald · Würzburg, DE
• German Ott · Bietigheim-Bissingen, DE

Key dates

• Filing date: Apr 27, 2018
• Grant date: Jun 8, 2021
• Expiry date: Oct 11, 2039

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/56
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.